What Seae Ventures does

Seae Ventures is a Boston-based, healthcare-focused venture capital firm founded in 2019 by Jason Robart and Tuoyo Louis. The firm invests in early-stage healthcare technology and services companies, with a deliberate concentration on founders who are women, Black, Indigenous, or people of color, and on solutions serving underserved populations including Medicaid beneficiaries, rural and low-income communities, and women. Seae operates a two-fund structure: Fund I closed in 2022 and Fund II closed in 2026, with Limited Partners spanning payers, providers, financial institutions, endowments, foundations, and family offices. In July 2024 Seae acquired Unseen Capital, a pre-seed/early seed vehicle focused on underrepresented founders, bringing total assets under management to over $200 million and adding a pre-seed/seed strategy layer led by Managing Partner Erica Murdock.

The combined Seae and Unseen portfolio spans 30+ companies across women's health, LGBTQ+ care, behavioral health, oncology, chronic disease, caregiver support, and healthcare infrastructure. Notable holdings include Tia Health, FOLX Health, Iterative Health, Trial Library, Kiyatec, MyMeds, Bloomwell Behavioral Health, Nolia, Health In Her Hue, Plume Clinic, and Willow Health, with several AI- and data-driven platforms (computer vision diagnostics, predictive oncology, AI-enabled clinical-trial matching, predictive analytics for chronic disease) anchoring the technology thesis. Beyond capital, Seae offers portfolio companies clinical advisory support, LP network access, cross-portfolio collaboration, and a Getro-powered job board, and publishes proprietary thought leadership through the Seae Perspectives series covering behavioral health, primary care, fertility, chronic disease, and addiction reimbursement.

Seae's revenue model is standard venture fund economics: management fees (typically ~2% of committed capital) paid by LPs to the GP, plus carried interest (typically ~20% of fund profits above a hurdle) realized upon exit. Fund I (closed 2022) and Fund II (closed 2026) are the primary revenue drivers, with carried-interest realization dependent on future portfolio exits. The firm is privately held, has no parent company, is registered as Seae Ventures LLC in Massachusetts, and maintains a New York leadership presence alongside its Boston headquarters.

Name

Seae Ventures

Legal name

Seae Ventures LLC

Website

https://seaeventures.com

Company type

Private

Founded year

2019

Operating status

Operating

Headcount range

1–10 employees

Short description

Seae Ventures is a Boston-based healthcare venture capital firm investing in early-stage companies founded by underrepresented entrepreneurs serving underserved populations, managing $200M+ in AUM across Fund I, Fund II, and the acquired Unseen Capital seed vehicle.

Ownership category

akta.pro rank

Product category

Venture Capital (Healthcare-Focused)

NAICS

Portfolio Management and Investment Advice (523940), Other Investment Pools and Funds (5259)

SIC

Investment Advice (6282)

akta.pro primary industry

Early-Stage Venture Capital (Series A/B) (FSANAAAB)

akta.pro secondary industries

Sustainable Private Markets (Impact PE/VC, Private Credit, Infrastructure) (FSAAALAG), Emerging Manager / Seeding Platforms (Multi-Manager) (FSANAGAF)

Keywords

• Healthcare venture capital
• Early-stage investments
• Health equity investing
• Diverse founder funding
• Healthcare innovation funding

Headquarters

HQ city

Boston

HQ country

United States

HQ region

North America

Offices2 records

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Operations, Marketing or Sales, Technology or R&D, Others

Revenue model

1. Venture Capital Fund Management: Seae Ventures generates returns for Limited Partners (including payers, providers, financial institutions, endowments, foundations, and family offices) by investing equity in early-stage healthcare companies and realizing returns through exits (IPOs, acquisitions). Revenue accrues to the fund structure via management fees and carried interest.

Go-to-market motion1 record

Distribution channels1 record

Marketing channels5 records

Core offering

Seae Ventures is a healthcare-focused venture capital firm that manages investment funds (Fund I closed 2022, Fund II closed 2026) and an acquired pre-seed/early seed vehicle (Unseen Capital, acquired 2024). The firm invests equity capital in early-stage healthcare technology and services companies primarily founded by women and people who identify as Black, Indigenous, and people of color, targeting solutions that expand access, reduce cost, integrate behavioral health, and strengthen provider infrastructure. Combined assets under management exceed $200 million across 30+ portfolio companies.

Product overview

Seae Ventures is a healthcare-focused venture capital investment firm (not a technology product company) that operates multiple investment funds (Fund I, Fund II) and an acquired early seed vehicle (Unseen Capital). The firm supports a portfolio of 30+ healthcare companies across women's health, LGBTQ+ care, chronic disease management, behavioral health, cancer care, caregiver support, health equity, and healthcare infrastructure. Beyond capital deployment, Seae offers thought leadership publications (Seae Perspectives annual reports, white papers), a fellows program for underrepresented students in VC, and a job board powered by Getro Inc. for portfolio companies. The portfolio includes AI-enabled platforms (Nolia, Trial Library, Iterative Health), predictive analytics tools (Kiyatec, MyMeds), telehealth providers (Tia Health, FOLX Health, Willow Health), and various digital health solutions addressing healthcare access and equity for underserved populations.

Differentiator

Problem solved

Functional benefit

Brands

• Unseen Capital: Pre-seed/early seed investment vehicle acquired by Seae Ventures in 2024, focused on investing in innovators familiar with challenges faced by marginalized communities, honoring the legacy of founder Kayode Owens.

Products and services

• Seae Ventures Fund I Seae Ventures' inaugural investment fund for making equity investments in early-stage healthcare technology and services companies. Capital is deployed through Fund I into portfolio companies targeting healthcare cost reduction, behavioral health integration, access expansion, and provider infrastructure.
• Seae Ventures Fund II Seae Ventures' second healthcare-focused investment fund, closed in 2026 to deploy capital into early-stage healthcare technology and services companies, building on Fund I learnings and adapting to changing marketplace dynamics.
• Unseen Capital (Pre-Seed/Early Seed Vehicle) Pre-seed/early seed investment vehicle acquired by Seae Ventures in 2024, focused on investing in innovators familiar with challenges faced by marginalized communities. Provides earlier-stage equity capital to underrepresented healthcare founders and integrates with Seae's clinical advisory and LP network.
• Seae Ventures Job Board

Quantifiable outcome

• 40% of portfolio companies serve Medicaid populations
• +4 more outcomes

Segments3 records

Ideal customer profiles2 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Integration5 records

AI capability18 records

Partnerships

One partnership is on record.

• Erica Murdock (Unseen Capital Managing Director)coreOthersErica Murdock, an experienced healthcare operator and prior founder, serves as Unseen's Managing Director following the acquisition. She leads the team supporting Unseen's existing portfolio and the go-forward early seed stage strategy. This is a leadership integration rather than a formal external partnership.

Scale indicators7 records

Recent moves8 records

Expansion highlights5 records

Broad incumbents

• Andreessen Horowitz (a16z Bio/Health): Andreessen Horowitz operates a significant healthcare and bio fund investing across stages in digital health, biotech, and care delivery. As a large, established investor it competes with Seae for premium healthcare deals and limited partner allocations.
• Optum Ventures: Optum Ventures is the corporate venture capital arm of UnitedHealth Group/Optum, focused on early-stage healthcare technology investments. It operates as a strategic investor with healthcare system access, comparable in scope but with deeper strategic LP backing than Seae.
• General Catalyst: General Catalyst is a major venture capital firm with a large healthcare practice investing across stages. While much larger and more diversified, it competes with Seae for healthcare deals, LP capital, and co-investment opportunities, particularly in digital health.

Emerging players

• Wavemaker 360 Health: Wavemaker 360 Health is an early-stage healthcare venture fund focused on digital health and tech-enabled healthcare services. As a smaller, healthcare-dedicated fund it has partial overlap with Seae's seed-stage investment focus and target founder profile.
• Jumpstart Nova: Jumpstart Nova is a venture capital firm investing in Black-founded healthcare companies at the seed and Series A stages. Its narrow focus on underrepresented healthcare founders creates strong overlap with Seae's diversity and equity investment thesis.

Direct peers

• Kapor Capital: Kapor Capital is an impact-focused venture capital firm that invests in tech startups closing gaps of access, opportunity, or outcome for underrepresented groups. Its focus on underrepresented founders and impact-driven returns aligns directly with Seae's diversity and equity thesis.
• Backstage Capital: Backstage Capital is a venture capital firm that invests in startups led by underrepresented founders, including women, people of color, and LGBTQ+ entrepreneurs. Its emphasis on underrepresented founder deal flow makes it a directly comparable diversity-focused early-stage investor.
• Define Ventures: Define Ventures is an early-stage healthcare venture capital firm that backs entrepreneurs building tech-enabled healthcare companies. As an early-stage specialist in digital health, it competes with Seae for similar founders, deal flow, and LP allocations.
• Town Hall Ventures: Town Hall Ventures is a healthcare-focused venture capital firm that invests in companies transforming care for underserved populations. Its thesis on health equity and focus on payers, providers, and community care directly mirrors Seae Ventures' investment approach and target founder profile.
• Oak HC/FT: Oak HC/FT is an early-stage venture capital firm focused exclusively on healthcare and fintech. It invests across seed to growth stages in healthcare technology companies, making it a directly comparable early-stage healthcare investor to Seae Ventures.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks5 records

Key highlights7 records

Customer concentration

• Xx.com/seaeventures

Compliance1 record

Revenue estimate

Valuation estimate

Number of profiles

Profiles10 records

Subsidiaries1 record

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A1 record

Investments26 records

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Seae Ventures